1407496-58-5

Basic information

• Product Name: N,N'-((4-fluorophenyl)methylene)bis(2-(4-(trifluoromethyl)phenyl)acetamide)
• Synonyms: N,N'-((4-fluorophenyl)methylene)bis(2-(4-(trifluoromethyl)phenyl)acetamide)
• CAS NO: 1407496-58-5
• Molecular Weight: 512.427
• Mol File: 1407496-58-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N,N'-((4-fluorophenyl)methylene)bis(2-(4-(trifluoromethyl)phenyl)acetamide)(CAS DataBase Reference)
• NIST Chemistry Reference: N,N'-((4-fluorophenyl)methylene)bis(2-(4-(trifluoromethyl)phenyl)acetamide)(1407496-58-5)
• EPA Substance Registry System: N,N'-((4-fluorophenyl)methylene)bis(2-(4-(trifluoromethyl)phenyl)acetamide)(1407496-58-5)

Safety Data

• Hazardous Substances Data: 1407496-58-5(Hazardous Substances Data)

Upstream product

• 41360-55-8 2-[(4-trifluoromethyl)phenyl]acetamide 
• 459-57-4 4-fluorobenzaldehyde 
• 2338-75-2 4-(Trifluoromethyl)phenylacetonitrile 

Relevant articles and documents

NOVEL CANNABINOID RECEPTOR 2 (CB2) INVERSE AGONISTS AND THERAPEUTIC POTENTIAL FOR MULTIPLE MYELOMA AND OSTEOPOROSIS BONE DISEASES

Cannabionid receptor-2 inverse antagonists include compounds represented by Formula IV, or a pharmaceutically acceptable salt thereof: wherein: R1 and R2 are independently H, alkyl, or alkenyl; R3 is alkyl, alkenyl, aryl, aralkyl, aralkenyl, heterocyclyl, heterocyclylalkyl, heteroaryl, heteroarylalkyl; R4 and R5 are independently a bond, alkylenyl, or alkenylenyl; each R6 and R7 is independently selected from the group consisting of OH, F, Cl, Br, I, (C1-C6)alkyl, alkoxy, amino, COOH, CONH2, SO3H, PO3H2, CN, SH, NO2 and CF3; and p and q are independently 0, 1, 2, 3, 4, or 5. Such compounds may be used to treat osteoporosis or multiple myeloma.